420
Views
6
CrossRef citations to date
0
Altmetric
Review

Double Trouble: Challenges in the Diagnosis and Management of Ocular Syphilis in HIV-infected Individuals

, MD, MScORCID Icon, , MMed FCOphth (SA), PhDORCID Icon, , MD, PhDORCID Icon & , MD, PhDORCID Icon

References

  • Centers for Disease Control and Prevention. CDC - clinical advisory: ocular syphilis in the United States. https://www.cdc.gov/std/syphilis/clinicaladvisoryos2015.htm. Accessed October 22, 2019.
  • Kuo IC, Kapusta MA, Rao NA. Vitritis as the primary manifestation of ocular syphilis in patients with HIV infection. Am J Ophthalmol. 1998;125(3):306–311. doi:10.1016/S0002-9394(99)80136-6.
  • Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus‐positive and negative patients. Clin Exp Ophthalmol. 2010;38(1):68–74. doi:10.1111/j.1442-9071.2010.02203.x.
  • Tran THC, Cassoux N, Bodaghi B, Fardeau C, Caumes E, Lehoang P. Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefe’s Arch Clin Exp Ophthalmol. 2005;243(9):863–869. doi:10.1007/s00417-005-1137-6.
  • Fonollosa A, Giralt J, Pelegrín L, et al. Ocular syphilis—back again: understanding recent increases in the incidence of ocular syphilitic disease. Ocul Immunol Inflamm. 2009;17(3):207–212. doi:10.1080/09273940902741709.
  • Smolak A, Rowley J, Nagelkerke N, et al. Trends and predictors of syphilis prevalence in the general population: global pooled analyses of 1103 prevalence measures including 136 million syphilis tests. Clin Infect Dis. 2018;66(8):1184–1191. doi:10.1093/cid/cix975.
  • Centers for Disease Control and Prevention. Syphilis - 2018 sexually transmitted diseases surveillance. https://www.cdc.gov/std/stats18/syphilis.htm. Accessed January 21, 2020.
  • European Centre for Disease Prevention and Control. Syphilis and congenital syphilis in Europe - a review of epidemiological trends (2007–2018) and options for response. https://www.ecdc.europa.eu/en/publications-data/syphilis-and-congenital-syphilis-europe-review-epidemiological-trends-2007-2018. Accessed January 21, 2020.
  • Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates. Bull World Health Organ. 2016;2019:548–562. doi:10.2471/BLT.18.228486.
  • Korenromp IEL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes-estimates for 2016 and progress since 2012. PloS One. 2019. doi:10.1371/journal.pone.0211720.
  • Birnbaum AD, Little DM, Tessler HH, Goldstein DA. Etiologies of chronic anterior uveitis at a tertiary referral center over 35 years. Ocul Immunol Inflamm. 2011;19(1):19–25. doi:10.3109/09273948.2010.519852.
  • Balba GP, Kumar PN, James AN, et al. Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med. 2006;119(5):448.e21–448.e25. doi:10.1016/j.amjmed.2005.11.016.
  • Cope AB, Mobley VL, Oliver SE, et al. Ocular syphilis and human immunodeficiency virus coinfection among syphilis patients in North Carolina, 2014–2016. Sex Transm Dis. 2019;46(2):80–85. doi:10.1097/OLQ.0000000000000910.
  • Pratas AC, Goldschmidt P, Lebeaux D, et al. Increase in ocular syphilis cases at ophthalmologic reference center, France, 2012–2015. Emerg Infect Dis. 2018;24(2):193–200. doi:10.3201/eid2402.171167.
  • Menard A, Meddeb L, Conrath J, Charrel RN, Colson P. Ocular syphilis, an old adversary is back in the old world too! AIDS. 2018;32(16):2433–2434. doi:10.1097/QAD.0000000000001973.
  • Nishijima T, Yashiro S, Teruya K, et al. Routine eye screening by an ophthalmologist is clinically useful for HIV-1-infected patients with CD4 count less than 200/μL. PLoS One. 2015;10:9. doi:10.1371/journal.pone.0136747.
  • Biotti D, Bidot S, Mahy S, et al. Ocular syphilis and HIV infection. Sex Transm Dis. 2010;37(1):41–43. doi:10.1097/OLQ.0b013e3181b3e4d8.
  • Hamze H, Ryan V, Cumming E, et al. Human immunodeficiency virus seropositivity and early syphilis stage associated with ocular syphilis diagnosis: a case-control study in British Columbia, Canada, 2010–2018. Clin Infect Dis. August 2019. doi:10.1093/cid/ciz794.
  • Tsen CL, Chen YS, Wu KS, et al. Ocular manifestations of human immunodeficiency virus infection at a tertiary referral center in Taiwan. Ocul Immunol Inflamm. 2019;27(7):1071–1076. doi:10.1080/09273948.2018.1499939.
  • Rothova A, Hajjaj A, de Hoog J, Thiadens AAHJ, Dalm VASH. Uveitis causes according to immune status of patients. Acta Ophthalmol. 2019;97(1):53–59. doi:10.1111/aos.13877.
  • Schaftenaar E, Meenken C, Baarsma GS, et al. Uveitis is predominantly of infectious origin in a high HIV and TB prevalence setting in rural South Africa. Br J Ophthalmol. 2016;100(10):1312–1316. doi:10.1136/bjophthalmol-2016-308645.
  • Rautenbach W, Steffen J, Smit D, Lecuona K, Esterhuizen T. Patterns of uveitis at two university-based referral centres in Cape Town, South Africa. Ocul Immunol Inflamm. 2019;27(6):868–874. doi:10.1080/09273948.2017.1391954.
  • Oliver SE, Cope AB, Rinsky JL, et al. Increases in ocular syphilis—North Carolina, 2014–2015. Clin Infect Dis. 2017;65(10):1676–1682. doi:10.1093/cid/cix604.
  • LaFond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev. 2006;19(1):29–49. doi:10.1128/CMR.19.1.29-49.2006.
  • Singh AE. Ocular and neurosyphilis. Curr Opin Infect Dis. 2020;33(1):66–72. doi:10.1097/QCO.0000000000000617.
  • Gjestland T. The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. Acta Derm Venereol Suppl (Stockh). 1955;35(Suppl 34):3–368; Annex I–LVI. http://www.ncbi.nlm.nih.gov/pubmed/13301322. Accessed January 21, 2020.
  • Roberts CP, Klausner JD. Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. Expert Rev Anti Infect Ther. 2016;14(11):1037–1046. doi:10.1080/14787210.2016.1236683.
  • Marra CM, Tantalo LC, Sahi SK, Dunaway SB, Lukehart SA. Reduced Treponema pallidum –specific opsonic antibody activity in HIV-infected patients with syphilis. J Infect Dis. 2016;213(8):1348–1354. doi:10.1093/infdis/jiv591.
  • Kotsafti O, Paparizos V, Kourkounti S, et al. Early syphilis affects markers of HIV infection. Int J STD AIDS. 2016;27(9):739–745. doi:10.1177/0956462415592326.
  • Chapel TA. The signs and symptoms of secondary syphilis. Sex Transm Dis. 1980;7(4):161–164. doi:10.1097/00007435-198010000-00002.
  • Hamill MM, Seppings L, Kit V, Antao S. concurrent primary chancre and ocular syphilis in an human immunodeficiency virus-negative man. Sex Transm Dis. 2018;45(12):e109–e112. doi:10.1097/OLQ.0000000000000900.
  • Ormerod LD, Puklin JE, Sobel JD. Syphilitic posterior uveitis: correlative findings and significance. Clin Infect Dis. 2001;32(12):1661–1673. doi:10.1086/320766.
  • Tsuboi M, Nishijima T, Yashiro S, et al. Time to development of ocular syphilis after syphilis infection. J Infect Chemother. 2018;24(1):75–77. doi:10.1016/j.jiac.2017.08.006.
  • Oliver S, Sahi SK, Tantalo LC, et al. Molecular typing of treponema pallidum in ocular syphilis. Sex Transm Dis. 2016;43(8):524–527. doi:10.1097/OLQ.0000000000000478.
  • Klein A, Fischer N, Goldstein M, Shulman S, Habot‐Wilner Z. The great imitator on the rise: ocular and optic nerve manifestations in patients with newly diagnosed syphilis. Acta Ophthalmol. 2019;97(4):e641–e647. doi:10.1111/aos.13963.
  • Tsuboi M, Nishijima T, Yashiro S, et al. Prognosis of ocular syphilis in patients infected with HIV in the antiretroviral therapy era. Sex Transm Infect. 2016;92(8):605–610. doi:10.1136/sextrans-2016-052568.
  • Furtado JM, Arantes TE, Nascimento H, et al. Clinical manifestations and ophthalmic outcomes of ocular syphilis at a time of re-emergence of the systemic infection. Sci Rep. 2018;8:1. doi:10.1038/s41598-018-30559-7.
  • Kiss S, Damico FM, Young LH. Ocular manifestations and treatment of syphilis. Semin Ophthalmol. 2005;20(3):161–167. doi:10.1080/08820530500232092.
  • Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369–376. doi:10.1086/381227.
  • Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis. 1998;177(4):931–940. doi:10.1086/515245.
  • Berry CD, Hooton TM, Collier AC, Lukehart SA. neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med. 1987;316(25):1587–1589. doi:10.1056/NEJM198706183162507.
  • Bollemeijer JG, Wieringa WG, Missotten TOAR, et al. Clinical manifestations and outcome of syphilitic uveitis. Investig Ophthalmol Vis Sci. 2016;57(2):404–411. doi:10.1167/iovs.15-17906.
  • Reekie I, Reddy Y. Use of lumbar punctures in the management of ocular syphilis. Semin Ophthalmol. 2018;33(2):271–274. doi:10.1080/08820538.2016.1228986.
  • Queiroz RDP, Inês DV, Diligenti FT, et al. The ghost of the great imitator: prognostic factors for poor outcome in syphilitic uveitis. J Ophthalmic Inflamm Infect. 2019. 9(1). doi:10.1186/s12348-019-0169-8.
  • Tucker JD, Li JZ, Robbins GK, et al. Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect. 2011;87(1):4–8. doi:10.1136/sti.2010.043042.
  • Hoogewoud F, Frumholtz L, Loubet P, et al. Prognostic factors in syphilitic uveitis. Ophthalmology. 2017;124:1808–1816. Elsevier Inc. doi:10.1016/j.ophtha.2017.06.003.
  • Aldave AJ, King JA, Cunningham ET, Tamesis RR, Foster CS. Ocular syphilis. Ophthalmology. 1990;97(10):1281–1287. doi:10.1097/00055735-200112000-00008.
  • Smith GT, Goldmeier D, Migdal C. Neurosyphilis with optic neuritis: an update. Postgrad Med J. 2006;82(963):36–39. doi:10.1136/pgmj.2004.020875.
  • Rajan MS, Pantelidis P, Tong CYW, French GL, Graham EM, Stanford MR. Diagnosis of Treponema pallidum in vitreous samples using real time polymerase chain reaction. Br J Ophthalmol. 2006;90(5):647–648. doi:10.1136/bjo.2005.083196.
  • Müller M, Ewert I, Hansmann F, et al. Detection of Treponema pallidum in the vitreous by PCR. Br J Ophthalmol. 2007;91(5):592–595. doi:10.1136/bjo.2006.110288.
  • Cornut PL, Sobas CR, Perard L, et al. Detection of Treponema pallidum in aqueous humor by real-time polymerase chain reaction. Ocul Immunol Inflamm. 2011;19(2):127–128. doi:10.3109/09273948.2010.531175.
  • Troutbeck R, Chhabra R, Jones NP. Polymerase chain reaction testing of vitreous in atypical ocular syphilis. Ocul Immunol Inflamm. 2013:1–4.
  • Smit D, De Graaf M, Meyer D, de Groot-mijnes JDF. Immunoblot and polymerase chain reaction to diagnose ocular syphilis and neurosyphilis in HIV-positive and HIV-negative patients. Ocul Immunol Inflamm. January 2020:1–7. doi:10.1080/09273948.2019.1698753.
  • Backhouse JL, Nesteroff SI. Treponema pallidum western blot: comparison with the FTA-ABS test as a confirmatory test for syphilis. Diagn Microbiol Infect Dis. 2001;39(1):9–14. doi:10.1016/S0732-8893(00)00213-3.
  • Bollensen E, Albrecht S, Beuche W, Mäder M, Prange HW. Reactivity of locally produced CSF antibodies in patients with neurosyphilis against antigens of Treponema pallidum. J Neurol. 1993;240(8):471–474. doi:10.1007/BF00874115.
  • Lauwen S, de Jong EK, Lefeber DJ, den Hollander AI. Omics biomarkers in ophthalmology. Investig Ophthalmol Vis Sci. 2017;58(6):BIO88–BIO98. doi:10.1167/iovs.17-21809.
  • Andreae CD, Smit DP, Makhoba NS, Kidd M, Walzl G, Chegou NN. Identification of potential biomarkers in peripheral blood supernatants of south african patients with syphilitic and herpetic uveitis. Ocul Immunol Inflamm. 2019:1–9. doi:10.1080/09273948.2019.1674341.
  • Mathew D, Smit D. Clinical and laboratory characteristics of ocular syphilis and neurosyphilis among individuals with and without HIV infection. Br J Ophthalmol. March 2020:bjophthalmol-2019-315699. doi:10.1136/bjophthalmol-2019-315699.
  • Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye. 2005;20(6):703–705. doi:10.1038/sj.eye.6701954.
  • Centers for Disease Control and Prevention. Syphilis - 2015 STD treatment guidelines. https://www.cdc.gov/std/tg2015/syphilis.htm. Accessed January 21, 2020.
  • Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS. Primer: syphilis. Nat Rev Dis Primers. 2017;3. doi:10.1038/nrdp.2017.73.
  • Gass JDM, Braunstein RA, Chenoweth RG. Acute syphilitic posterior placoid chorioretinitis. Ophthalmology. 1990;97(10):1288–1297. doi:10.1016/S0161-6420(90)32418-1.
  • Balaskas K, Sergentanis TN, Giulieri S, Guex-Crosier Y. Fluorescein and indocyanine-green angiography in ocular syphilis: an exploratory study. Graefe’s Arch Clin Exp Ophthalmol. 2012;250(5):721–730. doi:10.1007/s00417-011-1893-4.
  • Shen J, Feng L, Li Y. Ocular syphilis: an alarming infectious eye disease. Int J Clin Exp Med. 2015;8:7770–7777.
  • Joseph A, Rogers S, Browning A, et al. Syphilitic acute posterior placoid chorioretinitis in nonimmuno-compromised patients. Eye. 2007;21(8):1114–1119. doi:10.1038/sj.eye.6702504.
  • Pichi F, Ciardella AP, Cunningham ET, et al. Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina. 2014;34(2):373–384. doi:10.1097/IAE.0b013e3182993f11.
  • Schlaen A, Ingolotti M, Couto C, Saravia M. Spectral optical coherence tomography findings in an elderly patient with syphilitic bilateral chronic panuveitis. Am J Ophthalmol Case Rep. 2018;9:56–61. doi:10.1016/j.ajoc.2018.01.012.
  • Lima BR, Mandelcorn ED, Bakshi N, Nussenblatt RB, Nida Sen H. Syphilitic outer retinopathy. Ocul Immunol Inflamm. 2014;22(1):4–8. doi:10.3109/09273948.2013.841960.
  • Lewis DA, Lukehart SA. Antimicrobial resistance in Neisseria gonorrhoeae and Treponema pallidum: evolution, therapeutic challenges and the need to strengthen global surveillance. Sex Transm Infect. 2011;87(Suppl):2. doi:10.1136/sti.2010.047712.
  • Nurse-Findlay S, Taylor MM, Savage M, et al. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews. PLoS Med. 2017;14:12. doi:10.1371/journal.pmed.1002473.
  • Liu HY, Han Y, Chen XS, et al. Comparison of efficacy of treatments for early syphilis: A systematic review and network meta-analysis of randomized controlled trials and observational studies. PLoS One. 2017;12:6. doi:10.1371/journal.pone.0180001.
  • Puech C, Gennai S, Pavese P, et al. Ocular manifestations of syphilis: recent cases over a 2.5-year period. Graefe’s Arch Clin Exp Ophthalmol. 2010;248(11):1623–1629. doi:10.1007/s00417-010-1481-z.
  • Balaskas K, Sergentanis TN, Giulieri S, Guex-Crosier Y. Analysis of significant factors influencing visual acuity in ocular syphilis. Br J Ophthalmol. 2011;95(11):1568–1572. doi:10.1136/bjo.2010.194498.
  • Agostini FA, Queiroz RP, Azevedo DOM, Henriques JF, Campos WR, Vasconcelos-Santos DV. Intravenous ceftriaxone for syphilitic uveitis. Ocul Immunol Inflamm. 2018;26(7):1059–1065. doi:10.1080/09273948.2017.1311926.
  • Moradi A, Salek S, Daniel E, et al. Clinical features and incidence rates of ocular complications in patients with ocular syphilis. Am J Ophthalmol. 2015;159(2):334–343.e1. doi:10.1016/j.ajo.2014.10.030.
  • Fonollosa A, Martinez-Indart L, Artaraz J, et al. Clinical manifestations and outcomes of syphilis-associated uveitis in Northern Spain. Ocul Immunol Inflamm. 2016;24(2):147–152. doi:10.3109/09273948.2014.943349.
  • Yang P, Zhang N, Li F, Chen Y, Kijlstra A. Ocular manifestations of syphilitic uveitis in chinese patients. Retina. 2012;32(9):1906–1914. doi:10.1097/IAE.0b013e3182509796.
  • Blank LJ, Rompalo AM, Erbelding EJ, Zenilman JM, Ghanem KG. Treatment of syphilis in HIV-infected subjects: a systematic review of the literature. Sex Transm Infect. 2011;87(1):9–16. doi:10.1136/sti.2010.043893.
  • Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007;83(2):97–101. doi:10.1136/sti.2006.021402.
  • González‐López JJ, Guerrero MLF, Luján R, Tostado SF, de Górgolas M, Requena L. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis. 2009;49(10):1505–1511. doi:10.1086/644618.
  • Seña AC, Zhang X-H, Li T, et al. A systematic review of syphilis serological treatment outcomes in HIV-infected and HIV-uninfected persons: rethinking the significance of serological non-responsiveness and the serofast state after therapy. BMC Infect Dis. 2015;15(1):479. doi:10.1186/s12879-015-1209-0.
  • Zhang R, Qian J, Guo J, et al. Clinical manifestations and treatment outcomes of syphilitic uveitis in a Chinese population. J Ophthalmol. 2016;2016:1–8. doi:10.1155/2016/2797028.
  • Chao JR, Khurana RN, Fawzi AA, Reddy HS, Rao NA. Syphilis: reemergence of an old adversary. Ophthalmology. 2006;113(11):2074–2079. doi:10.1016/j.ophtha.2006.05.048.
  • Mathew RG, Goh BT, Westcott MC. British ocular syphilis study (BOSS): 2-year national surveillance study of intraocular inflammation secondary to ocular syphilis. Invest Ophthalmol Vis Sci. 2014;55(8):5394–5400. doi:10.1167/iovs.14-14559.
  • Queiroz RDP, Diniz AV, Vasconcelos-Santos DV. Fulminant proliferative vitreoretinopathy in syphilitic uveitis. J Ophthalmic Inflamm Infect. 2016;6(1):6. doi:10.1186/s12348-016-0075-2.
  • Northey LC, Skalicky SE, Gurbaxani A, McCluskey PJ. Syphilitic uveitis and optic neuritis in Sydney, Australia. Br J Ophthalmol. 2015;99(9):1215–1219. doi:10.1136/bjophthalmol-2014-306168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.